FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996217966> ?p ?o ?g. }

• W1996217966 endingPage "2050" @default.
• W1996217966 startingPage "2039" @default.
• W1996217966 abstract "The ability to predict which patients are most likely to achieve a sustained virologic response (SVR) with peginterferon/ribavirin would be useful in optimizing treatment for hepatitis C virus (HCV). The objective of this large international noninterventional cohort study was to investigate the predictive value (PV) of a virologic response (VR) by weeks 2, 4, and 12 of treatment on SVR. Treatment-naive HCV monoinfected patients (N = 7,163) age ≥18 years were prescribed peginterferon/ribavirin at the discretion of the treating physician according to country-specific requirements in accordance with the local label. The main outcome measure was the PV of a VR (HCV RNA <50 IU/mL) by weeks 2, 4, and 12 of treatment for SVR24 (HCV RNA <50 IU/mL after 24 weeks of untreated follow-up) by HCV genotype. The overall SVR24 rate was 49.4% (3,541/7,163; 95% confidence interval [CI]: 48.3-50.6%). SVR24 rates in patients with an HCV RNA titer <50 IU/mL by weeks 2, 4, and 12, respectively, were 66.2% (95% CI: 60.4-71.7%), 68.4% (95% CI: 65.7-71.0%), and 60.3% (95% CI: 58.5-62.1%) among genotype 1 patients; 82.0% (95% CI: 76.8-86.5%), 76.3% (95% CI: 73.3-79.1%), and 74.2% (95% CI: 71.3-76.9%) among genotype 2 patients; 67.3% (95% CI: 61.1-73.1%), 67.3% (95% CI: 64.2-70.3%), and 63.8% (95% CI: 61.0-66.6%) among genotype 3 patients; and 59.4% (95% CI: 40.6-76.3%), 63.3% (95% CI: 54.3-71.6%), and 54.3% (95% CI: 47.5-60.9%) among genotype 4 patients. The absence of a VR by week 12 had the highest negative PV across all genotypes. Conclusion: A VR by week 2 or 4 had the highest positive PV for SVR24 and differed according to HCV genotype. (HEPATOLOGY 2012;56:2039–2050)" @default.
• W1996217966 created "2016-06-24" @default.
• W1996217966 creator A5006679909 @default.
• W1996217966 creator A5010288279 @default.
• W1996217966 creator A5010968373 @default.
• W1996217966 creator A5011748970 @default.
• W1996217966 creator A5013141366 @default.
• W1996217966 creator A5013246678 @default.
• W1996217966 creator A5017882046 @default.
• W1996217966 creator A5018963659 @default.
• W1996217966 creator A5021496172 @default.
• W1996217966 creator A5041031293 @default.
• W1996217966 creator A5052742729 @default.
• W1996217966 creator A5054070286 @default.
• W1996217966 creator A5067743849 @default.
• W1996217966 creator A5073197069 @default.
• W1996217966 creator A5078642431 @default.
• W1996217966 creator A5085438139 @default.
• W1996217966 date "2012-08-08" @default.
• W1996217966 modified "2023-10-18" @default.
• W1996217966 title "High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials" @default.
• W1996217966 cites W1493700154 @default.
• W1996217966 cites W1975507313 @default.
• W1996217966 cites W1980390916 @default.
• W1996217966 cites W1993575761 @default.
• W1996217966 cites W1998859748 @default.
• W1996217966 cites W2013701901 @default.
• W1996217966 cites W2016203290 @default.
• W1996217966 cites W2017013905 @default.
• W1996217966 cites W2018446644 @default.
• W1996217966 cites W2027545702 @default.
• W1996217966 cites W2034654277 @default.
• W1996217966 cites W2040976734 @default.
• W1996217966 cites W2047208492 @default.
• W1996217966 cites W2057177770 @default.
• W1996217966 cites W2059247904 @default.
• W1996217966 cites W2063285149 @default.
• W1996217966 cites W2066808704 @default.
• W1996217966 cites W2070539863 @default.
• W1996217966 cites W2075282196 @default.
• W1996217966 cites W2077550422 @default.
• W1996217966 cites W2077719713 @default.
• W1996217966 cites W2100797437 @default.
• W1996217966 cites W2107512529 @default.
• W1996217966 cites W2112876622 @default.
• W1996217966 cites W2113864802 @default.
• W1996217966 cites W2125963799 @default.
• W1996217966 cites W2127685726 @default.
• W1996217966 cites W2143559032 @default.
• W1996217966 cites W2157961528 @default.
• W1996217966 cites W2170956924 @default.
• W1996217966 cites W2295623297 @default.
• W1996217966 cites W4211077792 @default.
• W1996217966 cites W4232907328 @default.
• W1996217966 doi "https://doi.org/10.1002/hep.25892" @default.
• W1996217966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22706730" @default.
• W1996217966 hasPublicationYear "2012" @default.
• W1996217966 type Work @default.
• W1996217966 sameAs 1996217966 @default.
• W1996217966 citedByCount "95" @default.
• W1996217966 countsByYear W19962179662013 @default.
• W1996217966 countsByYear W19962179662014 @default.
• W1996217966 countsByYear W19962179662015 @default.
• W1996217966 countsByYear W19962179662016 @default.
• W1996217966 countsByYear W19962179662017 @default.
• W1996217966 countsByYear W19962179662018 @default.
• W1996217966 countsByYear W19962179662019 @default.
• W1996217966 countsByYear W19962179662021 @default.
• W1996217966 countsByYear W19962179662022 @default.
• W1996217966 countsByYear W19962179662023 @default.
• W1996217966 crossrefType "journal-article" @default.
• W1996217966 hasAuthorship W1996217966A5006679909 @default.
• W1996217966 hasAuthorship W1996217966A5010288279 @default.
• W1996217966 hasAuthorship W1996217966A5010968373 @default.
• W1996217966 hasAuthorship W1996217966A5011748970 @default.
• W1996217966 hasAuthorship W1996217966A5013141366 @default.
• W1996217966 hasAuthorship W1996217966A5013246678 @default.
• W1996217966 hasAuthorship W1996217966A5017882046 @default.
• W1996217966 hasAuthorship W1996217966A5018963659 @default.
• W1996217966 hasAuthorship W1996217966A5021496172 @default.
• W1996217966 hasAuthorship W1996217966A5041031293 @default.
• W1996217966 hasAuthorship W1996217966A5052742729 @default.
• W1996217966 hasAuthorship W1996217966A5054070286 @default.
• W1996217966 hasAuthorship W1996217966A5067743849 @default.
• W1996217966 hasAuthorship W1996217966A5073197069 @default.
• W1996217966 hasAuthorship W1996217966A5078642431 @default.
• W1996217966 hasAuthorship W1996217966A5085438139 @default.
• W1996217966 hasConcept C104317684 @default.
• W1996217966 hasConcept C126322002 @default.
• W1996217966 hasConcept C135763542 @default.
• W1996217966 hasConcept C159047783 @default.
• W1996217966 hasConcept C2522874641 @default.
• W1996217966 hasConcept C2776408679 @default.
• W1996217966 hasConcept C2780040827 @default.
• W1996217966 hasConcept C32611913 @default.
• W1996217966 hasConcept C44249647 @default.
• W1996217966 hasConcept C55493867 @default.
• W1996217966 hasConcept C71924100 @default.

• next